Schrodinger Inc (SDGR)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, it appears that Schrodinger Inc has not reported any specific values for days of sales outstanding (DSO) for the years ending December 31, 2020 through December 31, 2024. This lack of information regarding DSO makes it challenging to assess the company's efficiency in collecting accounts receivable and managing its cash flow from sales. It is recommended that the company discloses more detailed financial data, including DSO figures, to provide investors and stakeholders with a clearer insight into its operational performance and liquidity management.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Schrodinger Inc
SDGR
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
90.15
Amphastar P
AMPH
67.96
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
7.07
Bristol-Myers Squibb Company
BMY
81.21
Catalyst Pharmaceuticals Inc
CPRX
—
Collegium Pharmaceutical Inc
COLL
—
Corcept Therapeutics Incorporated
CORT
—